drugset / Trial / NCT05766839
Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels
NaSingle-groupOpen-labelTreatment
Summary
A study to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer in children under 12 years of age with hyperkalaemia.
Timeline
- Start
- 2025-04-06
- Primary completion
- 2029-12-01
- Completion
- 2030-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patiromer | Other / unclassified | — | — |
Indications
No indication recorded.